Frequency and Mutation Patterns of Resistance in Patients with Chronic Hepatitis B Infection Treated with Nucleos(t)ide Analogs in Add-On and Switch Strategies

BACKGROUND: Treatment for chronic hepatitis B (CHB) has improved over the last 10 years mainly due to the development of effective oral antiviral agents [nucleoside/nucleotide analogs (NUCs)]. OBJECTIVES: The aim of the present study is to identify the frequency and major patterns of resistance to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayan, Murat, Akhan, Sila Cetin, Senturk, Omer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234585/
https://www.ncbi.nlm.nih.gov/pubmed/22224083
http://dx.doi.org/10.5812/kowsar.1735143X.775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234585/
https://www.ncbi.nlm.nih.gov/pubmed/22224083
http://dx.doi.org/10.5812/kowsar.1735143X.775

Ejemplares similares